Acral Lentiginous Melanoma Clinical Trials

ReadTheTrial indexes 2 studies for Acral Lentiginous Melanoma. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Acral Lentiginous Melanoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
Phase 1 1
50%

Trial Status Breakdown

Trials for Acral Lentiginous Melanoma

A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma

NCT03698019 · ACTIVE NOT RECRUITING · Phase 2

Phase I/Ib Study of Concurrent Intravenous and Intrathecal Nivolumab for Melanoma and Lung Cancer Patients With Leptomeningeal Disease (LMD)

NCT03025256 · RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Acral Lentiginous Melanoma?

There are 2 clinical trials listed for Acral Lentiginous Melanoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Acral Lentiginous Melanoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Acral Lentiginous Melanoma trials in?

Current Acral Lentiginous Melanoma trials are distributed across: Phase 2 (1), Phase 1 (1).

Find More Trials